UNION therapeutics appoints Dr. Kim Kjoeller as Chief Executive Officer and further strengthens leadership by appointing Dr. Günter Ditzinger as Chief Technology Officer
·UNION strengthens leadership following expansion of clinical pipeline from one to five later stage clinical candidates during 2020 · Dr. Kim Domela Kjoeller, Executive Vice President Global Research & Development at LEO Pharma A/S, has been appointed as new Chief Executive Officer with effect from January 1, 2021 · Dr. Günter Ditzinger, who holds 30 years of experience from Sanofi, Novartis and most recently as the Chief Technology Officer of Swiss-based Basilea Pharmaceutica, has been appointed as Chief Technology Officer Hellerup, Denmark, October 28, 2020 – UNION